DIVIS LABORATORIES
|
DIVIS LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity - Authorised | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Equity - Issued | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity Paid Up | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹14,916 Cr | ₹13,518 Cr | ₹12,714 Cr | ₹11,675 Cr | ₹9,242 Cr |
Securities Premium | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr | ₹7,598 Cr |
General Reserves | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr |
Other Reserves | ₹436 Cr | ₹652 Cr | ₹675 Cr | ₹606 Cr | ₹564 Cr |
Reserve excluding Revaluation Reserve | ₹14,916 Cr | ₹13,518 Cr | ₹12,714 Cr | ₹11,675 Cr | ₹9,242 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹14,969 Cr | ₹13,571 Cr | ₹12,767 Cr | ₹11,728 Cr | ₹9,295 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹498 Cr | ₹572 Cr | ₹523 Cr | ₹407 Cr | ₹335 Cr |
Deferred Tax Assets | ₹26 Cr | ₹30 Cr | ₹31 Cr | ₹36 Cr | ₹16 Cr |
Deferred Tax Liability | ₹524 Cr | ₹602 Cr | ₹554 Cr | ₹443 Cr | ₹351 Cr |
Other Long Term Liabilities | ₹2.00 Cr | ₹2.00 Cr | ₹3.00 Cr | ₹2.87 Cr | ₹3.69 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | ₹37 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr |
Total Non-Current Liabilities | ₹500 Cr | ₹611 Cr | ₹557 Cr | ₹437 Cr | ₹364 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹910 Cr | ₹824 Cr | ₹762 Cr | ₹796 Cr | ₹763 Cr |
Sundry Creditors | ₹910 Cr | ₹824 Cr | ₹762 Cr | ₹796 Cr | ₹763 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹486 Cr | ₹404 Cr | ₹332 Cr | ₹394 Cr | ₹340 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹40 Cr | ₹34 Cr | ₹33 Cr | ₹17 Cr | ₹16 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹446 Cr | ₹370 Cr | ₹299 Cr | ₹377 Cr | ₹324 Cr |
Short Term Borrowings | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
Secured ST Loans repayable on Demands | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
Working Capital Loans- Sec | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-2.00 Cr | - | - | - | ₹-0.35 Cr |
Short Term Provisions | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr | ₹624 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹796 Cr | ₹520 Cr | ₹440 Cr | ₹1,261 Cr | ₹622 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹54 Cr | ₹7.00 Cr | ₹5.00 Cr | ₹4.15 Cr | ₹2.51 Cr |
Total Current Liabilities | ₹2,248 Cr | ₹1,755 Cr | ₹1,539 Cr | ₹2,454 Cr | ₹1,728 Cr |
Total Liabilities | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr |
ASSETS | |||||
Gross Block | ₹7,868 Cr | ₹6,760 Cr | ₹6,365 Cr | ₹5,624 Cr | ₹4,692 Cr |
Less: Accumulated Depreciation | ₹2,426 Cr | ₹2,021 Cr | ₹1,643 Cr | ₹1,299 Cr | ₹988 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹5,442 Cr | ₹4,739 Cr | ₹4,722 Cr | ₹4,325 Cr | ₹3,704 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr | ₹711 Cr |
Non Current Investments | ₹65 Cr | ₹82 Cr | ₹77 Cr | ₹72 Cr | ₹0.01 Cr |
Long Term Investment | ₹65 Cr | ₹82 Cr | ₹77 Cr | ₹72 Cr | ₹0.01 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹65 Cr | ₹82 Cr | ₹77 Cr | ₹72 Cr | ₹0.01 Cr |
Long Term Loans & Advances | ₹301 Cr | ₹176 Cr | ₹97 Cr | ₹134 Cr | ₹173 Cr |
Other Non Current Assets | ₹10.00 Cr | ₹10.00 Cr | ₹5.00 Cr | ₹8.05 Cr | ₹9.21 Cr |
Total Non-Current Assets | ₹6,840 Cr | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹3,236 Cr | ₹3,184 Cr | ₹3,000 Cr | ₹2,829 Cr | ₹2,145 Cr |
Raw Materials | ₹1,037 Cr | ₹1,091 Cr | ₹972 Cr | ₹773 Cr | ₹706 Cr |
Work-in Progress | ₹1,698 Cr | ₹1,620 Cr | ₹1,526 Cr | ₹1,532 Cr | ₹1,093 Cr |
Finished Goods | ₹129 Cr | ₹150 Cr | ₹175 Cr | ₹154 Cr | ₹99 Cr |
Packing Materials | ₹9.00 Cr | ₹8.00 Cr | ₹9.00 Cr | ₹9.16 Cr | ₹8.38 Cr |
Stores  and Spare | ₹157 Cr | ₹148 Cr | ₹191 Cr | ₹196 Cr | ₹104 Cr |
Other Inventory | ₹206 Cr | ₹167 Cr | ₹127 Cr | ₹165 Cr | ₹134 Cr |
Sundry Debtors | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr |
Debtors more than Six months | ₹17 Cr | ₹18 Cr | ₹11 Cr | ₹10 Cr | ₹14 Cr |
Debtors Others | ₹2,721 Cr | ₹2,148 Cr | ₹1,788 Cr | ₹2,419 Cr | ₹1,668 Cr |
Cash and Bank | ₹3,715 Cr | ₹3,980 Cr | ₹4,214 Cr | ₹2,819 Cr | ₹2,156 Cr |
Cash in hand | ₹1.00 Cr | ₹1.00 Cr | ₹1.00 Cr | ₹0.71 Cr | ₹0.75 Cr |
Balances at Bank | ₹3,714 Cr | ₹3,979 Cr | ₹4,213 Cr | ₹2,818 Cr | ₹2,155 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹39 Cr | ₹38 Cr | ₹28 Cr | ₹30 Cr | ₹52 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹37 Cr | ₹36 Cr | ₹26 Cr | ₹27 Cr | ₹23 Cr |
Other current_assets | ₹2.00 Cr | ₹2.00 Cr | ₹2.00 Cr | ₹2.60 Cr | ₹29 Cr |
Short Term Loans and Advances | ₹1,156 Cr | ₹794 Cr | ₹715 Cr | ₹1,509 Cr | ₹761 Cr |
Advances recoverable in cash or in kind | ₹87 Cr | ₹80 Cr | ₹34 Cr | ₹87 Cr | ₹31 Cr |
Advance income tax and TDS | ₹809 Cr | ₹505 Cr | ₹536 Cr | ₹1,317 Cr | ₹650 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹260 Cr | ₹209 Cr | ₹145 Cr | ₹105 Cr | ₹80 Cr |
Total Current Assets | ₹10,877 Cr | ₹10,152 Cr | ₹9,750 Cr | ₹9,610 Cr | ₹6,791 Cr |
Net Current Assets (Including Current Investments) | ₹8,629 Cr | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr |
Contingent Liabilities | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr | ₹7.06 Cr |
Total Debt | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
Book Value | 564.87 | 512.11 | 481.77 | 441.82 | 350.15 |
Adjusted Book Value | 564.87 | 512.11 | 481.77 | 441.82 | 350.15 |
Compare Balance Sheet of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹180,152.4 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
MANKIND PHARMA | ₹108,985.0 Cr | 2.4% | 12.2% | 22.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.7% |
3.8% |
49.3% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses